Abeona Therapeutics (ABEO) Depreciation & Amortization - Total (2012)
Abeona Therapeutics (ABEO) recorded quarterly Depreciation & Amortization - Total of $29000.0 in Q4 2012.
Abeona Therapeutics (ABEO) Depreciation & Amortization - Total (2012) Analysis & Trends
Abeona Therapeutics' Depreciation & Amortization - Total history runs 1 years deep, the most recent figure standing at $29000.0 for Q4 2012.
- In Q4 2012, Depreciation & Amortization - Total changed N/A year-over-year to $29000.0; the TTM figure through Sep 2013 stood at $29000.0 (changed N/A YoY), while the FY2012 annual figure was $29000.0, changed N/A from the prior year.
- Depreciation & Amortization - Total was $29000.0 for Q4 2012 at Abeona Therapeutics.
- In the past five years, Depreciation & Amortization - Total ranged from a high of $29000.0 in Q4 2012 to a low of $29000.0 in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Abeona Therapeutics | 309.15 Mn | 140.88 Mn | 6.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 29,000.00 |